6311 - 6320 of 8808 Results
Title
Year
-
RESTRICTEDTitle: Autophagy activation ameliorates cognitive deficits and alpha-synuclein pathology in an adeno-associated viral vector mediated rat model of Lewy body disordersJournal Name: Pharmacology Biochemistry and BehaviorPublisher: Elsevier BVVol: 257Issue #:Start Page: 174096End Page: 174096Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pbb.2025.174096Citation Count: 0
-
OPENTitle: A functionalized hydroxydopamine quinone links thiol modification to neuronal cell deathJournal Name: Redox BiologyPublisher: Elsevier BVVol: 28Issue #:Start Page: 101377End Page: 101377Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.redox.2019.101377Best OA location URL: https://doi.org/10.1016/j.redox.2019.101377Citation Count: 27
-
OPENTitle: Biallelic NDUFA9 variants cause a progressive neurodevelopmental disorder with prominent dystonia and mitochondrial complex I deficiencyJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf369Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcaf369/64356002/fcaf369.pdfCitation Count: 0
-
OPENTitle: Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13024-022-00520-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-022-00520-4Citation Count: 15
-
OPENTitle: The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptorJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-018-1100-1Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-018-1100-1Citation Count: 148
-
OPENTitle: Human plasma biomarker responses to inhalational general anaesthesia without surgeryJournal Name: British Journal of AnaesthesiaPublisher: Elsevier BVVol: 125Issue #: 3Start Page: 282End Page: 290Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bja.2020.04.085Best OA location URL: http://www.bjanaesthesia.org/article/S0007091220303391/pdfCitation Count: 40
- Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects2014OPENTitle: Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjectsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 571Issue #:Start Page: 34End Page: 38Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2014.04.027Best OA location URL: http://doi.org/10.1016/j.neulet.2014.04.027Citation Count: 130
-
OPENTitle: Poly (ADP-ribose) Interacts With Phosphorylated α-Synuclein in Post Mortem PD SamplesJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page: 704041End Page: 704041Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.704041Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.704041/pdfCitation Count: 23
-
OPENTitle: Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegenerationJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 119Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2121609119Best OA location URL: https://escholarship.org/uc/item/4pt523rvCitation Count: 40
-
OPENTitle: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 UpdateJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 4Start Page: 427End Page: 439Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-239901Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd239901?id=journal-of-parkinsons-disease%2Fjpd239901Citation Count: 62